Amedisys (AMED) Reports In-Line Q1 EPS
Tweet
Share
E-mail
Get Alerts AMED Hot Sheet
Price: $100.99 --0%
Financial Fact:
Interest expense: -1.14M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Financial Fact:
Interest expense: -1.14M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Amedisys (NASDAQ: AMED) reported Q1 EPS of $0.33, in-line with the analyst estimate of $0.33. Revenue for the quarter came in at $348.8 million versus the consensus estimate of $337.07 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cerebras CEO says investors misunderstood margin guidance
- Hertz cuts guidance, announces notes and stock offerings, shares sink
- Morgan Stanley raises dividend 15% and approves $20B buyback program
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
